【其他高分选 062】

BC

PMID: 39189901

IF:12.1

Accuracy of an Artificial Intelligence System for Interval Breast Cancer Detection at Screening Mammography

PMID:39189475

IF:14.3

mRNA-Lipid Nanoparticle-Mediated Restoration of PTPN14 Exhibits Antitumor Effects by Overcoming Anoikis Resistance in Triple-Negative Breast Cancer

PMID:39187844

IF:10.4

The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models

PMID:39187583

IF:38.1

Metal-ion-chelating phenylalanine nanostructures reverse immune dysfunction and sensitize breast tumour to immune checkpoint blockade

PMID:39193992

IF:29.7

MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast Cancer

PMID:39215346

IF:11.4

USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing Eralpha

PMID:39215099

IF:12.9

Direct inhibition of tumor hypoxia response with synthetic transcriptional repressors

PMID:39215014

IF:14.7

AI-powered omics-based drug pair discovery for pyroptosis therapy targeting triple-negative breast cancer

PMID:39214982

IF:14.7

Comparison of AI-integrated pathways with human-AI interaction in population mammographic screening for breast cancer

PMID:39214974

IF:14.7

Self-immolative poly(thiocarbamate) with localized H(2)S signal amplification for precise cancer imaging and therapy

PMID:39213364

IF:11.7

Multi-armored allogeneic MUC1 CAR T cells enhance efficacy and safety in triple-negative breast cancer

PMID:39212621

IF:13

Sequential Responsive Multifunctional Nanomicelle Effectuates Collective Elimination of Breast Cancer and Cancer Stem Cells

PMID:39210244

IF:16.4

ENPP1 induces blood-brain barrier dysfunction and promotes brain metastasis formation in HER2-positive breast cancer

PMID:39209451

IF:10.3

Neutralizing IL-38 activates γδ T cell-dependent antitumor immunity and sensitizes for chemotherapy

PMID:39207783

IF:22.5

Neoadjuvant Immunotherapy-From Trials to Practice

PMID:39207756

IF:10.5

Surgeon and Care Team Network Measures and Timely Breast Cancer Treatment.

PMID:39207755

IF:10.5

Persistent Neighborhood Poverty and Breast Cancer Outcomes

PMID:39206932

IF:14.3

Tuning Immune-Cold Tumor by Suppressing USP10/B7-H4 Proteolytic Axis Reinvigorates Therapeutic Efficacy of ADCs

PMID:39205549

IF:10

Intraoperative Cavity Local Delivery System with NETs-Specific Drug Release for Post-Breast Cancer Surgery Recurrence Correction

PMID:39205539

IF:10

Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer

PMID:39214650

IF:10.3

Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironment

PMID:39216500

IF:41.6

Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE

PMID:39215346

IF:11.4

USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing Eralpha

PMID:39207756

IF:10.5

Surgeon and Care Team Network Measures and Timely Breast Cancer Treatmen

CRC

PMID:39189910

IF:12.1

Identifying Complete Responders Following Chemotherapy-only Neoadjuvant Treatment for Rectal Cancer: Role of MRI

PMID:39187583

IF:38.1